|
1.1means use of Executable Code, Software or Documentation by Licensee for direct or indirect financial, commercial or strategic gain or advantage, including without limitation: (a) bundling or integrating the Software with any hardware product or another software product for transfer, sale or license to a third party (even if distributing the Software on separate media and not charging for the Software); (b) providing third parties with a link to the Executable Code, Software or Documentation or a copy of the Executable Code, Software or Documentation for use with hardware or another software product purchased by that third party; or (c) use in connection with the performance of services for which Licensee is compensated. Notwithstanding the foregoing, use of Executable Code, Software or Documentation by Licensee for the Purpose (as defined above) is not considered Commercial Use. 1.2means any improvements to, modifications, language translations, programming language translations, or other derivative works of, the Executable Code, Software or Documentation made by Licensee. 1.3means documentation in paper, electronic or digital format reasonably necessary to utilize Software. Documentation shall include, without limitation, such documents and manuals that collectively contain a complete description and definition of any Software operations, and any user guides useful and/or necessary for the operation and management of any Software in the appropriate language(s) and formats, including design documents and test plans. 1.4指许可证人向被许可人提供的可执行程序文件。 1.5是指单击“接受”按钮或安装或以其他方式使用该代码的人员或实体,因此已同意此处的条款和条件,并在此处行使权利。 1.6means the output of a compiler after it processes source code, including but not limited to, code in the form of machine language that is directly executable by a microprocessor. For clarification, object code also includes machine code files that are that require linking with other object code files (e.g. libraries) to produce a complete executable program. 1.7means the computer program(s) referred to as “Turf v2.0.1” (University’s Technology Report No. 2011-0011 and 2013-0004) made available under this Agreement, including but not limited to, Executable Code, Source Code, Object Code, any error corrections, bug fixes, patches, Updates, Upgrades, modifications, enhancements, improvements, additions, derivative works, know-how, processes, procedures, compositions, methods, formulas, protocols, techniques, designs, drawings, materials, data, or any documentation or related materials that Licensor may in its sole discretion make available to Licensee from time to time, and any object code compiled from such source code. Software also includes Derivative Products. 1.8means any collection of computer instructions, including comments all modules it contains, associated interface definition files, scripts used to control compilation and installation of an executable format program, and that which is written using human-readable computer language, such as text.
|
|
|
3.1被许可方不得:(a)将,子许可或以其他方式分配给可执行的代码或软件或文档;(b)使用可执行的代码或软件或文档的任何部分进行商业使用,或用于第2节所述的任何其他用途;(c)复制文档或可执行代码的任何部分,而不是用于档案和备份目的;(d)从可执行代码或文档中删除任何产品标识,版权,专有标记,专利标记或标签;或(e)修改,翻译或创建可执行代码或文档的全部或任何部分的衍生作品或衍生产品,或重复使用,拆卸,反编译,反向工程或以其他方式翻译可执行的代码或文档或任何部分它。本协议除本协议中明确授予的授权书外,没有对被许可人的权利。 3.2 In the event that Licensee creates unauthorized derivative works or Derivative Products, Licensee hereby agrees that it will provide a copy of all derivative works or Derivative Products to Licensor and that Licensee’s use of the derivative works or Derivative Products will be subject to all of the same terms, conditions, restrictions and limitations on use imposed on the Software and Documentation under this Agreement. Furthermore, all rights to, title to, and interest in derivative works of the Software or Documentation created by Licensee or any agent or employee of Licensee shall be owned by and does hereby vest in Licensor. Licensee hereby irrevocably assigns, conveys, and transfers to Licensor and its successors, all rights, title and interest in and to such derivative works and Derivative Products. Licensee agrees to take all reasonably necessary steps that will allow Licensor to establish and demonstrate ownership of any unauthorized derivative works or Derivative Products. 3.3 LICENSEE IS EXPRESSLY PROHIBITED FROM TRANSFERRING, SENDING, OR STORING ANY PROTECTED HEALTH INFORMATION TO LICENSOR OR LICENSOR’S NETWORK OR SERVERS.
|
|
|
4.1机密性。可执行的代码,软件和文档是许可人的机密,有价值和专有信息。被许可人应采取足够的步骤来保护可执行的代码,软件和文档免受未经授权的披露或使用。被许可人同意,它不会向任何第三方披露可执行的代码,软件或文档或其任何部分。被许可人将至少行使其保护自己的机密,有价值和专有信息的合理护理标准。 4.2专有通知。被许可人应维护并放置其复制的任何软件,可执行代码或文档的副本,以供内部使用所有授权和/或所需的所有通知。被许可方应包括本协议的副本和软件的每个副本,可执行代码和文档的以下通知。该许可证和通知应嵌入可执行代码的每个副本中,视频屏幕显示,体现可执行代码副本的物理介质以及任何文档: Copyright © 2013 , The University of Texas Health Science Center at Houston. All rights reserved. UNIVERSITY EXPRESSLY DISCLAIMS ANY AND ALL WARRANTIES CONCERNING THE SOFTWARE AND DOCUMENTATION, INCLUDING BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR ANY PARTICULAR PURPOSE, NON-INFRINGEMENT AND WARRANTIES OF PERFORMANCE, AND ANY WARRANTY THAT MIGHT OTHERWISE ARISE FROM COURSE OF DEALING OR USAGE OF TRADE. NO WARRANTY IS EITHER EXPRESS OR IMPLIED WITH RESPECT TO THE USE OF THE SOFTWARE OR DOCUMENTATION. Under no circumstances shall University be liable for incidental, special, indirect, direct or consequential damages or loss of profits, interruption of business, or related expenses which may arise from use of the Software or Documentation, including but not limited to those resulting from defects in Software and/or Documentation, or loss or inaccuracy of data of any kind.
|
|
|
11.1如果本规定应持有非法,无效或不可执行的全部或部分规定,则该规定应在必要的最低范围内修改,以使其合法,有效和可执行,以及所有其他所有其他规定的合法性,有效性和可执行性本协议中不应受到影响。 11.2 Licensee may not assign this Agreement in whole or in part, without Licensor’s prior written consent. Any attempt to assign this Agreement without such consent will be null and void. 11.3本协议是与此处的主题有关的被许可人与许可方之间的完整和独家陈述,并取代所有先前的口头和书面以及所有同期的口头谈判,当事方的承诺和理解(如果有)。 11.4任何一方对任何违约或违反本协议的任何豁免均不构成对本协议的任何规定或随后的任何违约或违反相同或其他类型的豁免。 11.5本协议具有约束力,对当事方的利益具有约束力,其各自的执行人,管理者,继承人,允许分配和允许的继任者。 11.6标题仅是为了方便的,不会用于解释协议。 11.7被许可人应遵守所有适用的联邦,州和地方法律法规,包括无限制的所有出口法律法规。 11.8 Nothing in this Agreement shall be deemed or treated as any waiver of Licensor’s sovereign immunity. 11.9任何通知,问题,疑虑或其他允许或根据本协议进行的通讯或其他沟通将以书面形式进行,并在以提供确认或确认交货方式的方式时被视为有效,并在规定的地址上收到: The University of Texas Health Science Center at Houston 技术管理办公室 7000 Fannin Street,Suite 720 Houston, Texas 77030 FAX: 713-500-0331 PHONE: 713-500-3369 EMAIL: uthsch-otm@uth.tmc.edu
|
|